"10.1371_journal.pone.0073449","plos one","2013-09-25T00:00:00Z","Yuji Nakada; Thomas G Stewart; Christopher G Pe√±a; Song Zhang; Ni Zhao; Nabeel Bardeesy; Norman E Sharpless; Kwok-Kin Wong; D Neil Hayes; Diego H Castrillon","Department of Pathology and Simmons Cancer Center, UT Southwestern Medical Center, Dallas, Texas, United States of America; Departments of Medicine and Genetics, The Lineberger Comprehensive Cancer Center and University of North Carolina, Chapel Hill, North Carolina, United States of America; Department of Clinical Sciences, UT Southwestern Medical Center, Dallas, Texas, United States of America; Massachusetts General Hospital Cancer Center and Harvard Medical School, Cambridge, Massachusetts, United States of America; Department of Medicine, Harvard of Medical School and Dana Farber Cancer Institute, Boston, Massachusetts, United States of America","Conceived and designed the experiments: YN TS CP SZ NB NS KW NH DC. Performed the experiments: YN TS CP SZ. Analyzed the data: YN TS CP SZ NB NS KW NH DC NZ. Wrote the paper: YN TS NH DC.","DC, KW, NB and NS are inventors on an application (United States patent pending) of DNA-based methods to employ LKB1 status for diagnostic and prognostic clinical tests. This invention does not utilize the methods or antibody described in this manuscript. These investigators are paid consultants of Molecular MD (Portland, OR), which has a license agreement with these authors respective academic institutions. NH is an inventor on an application (United States patent pending) for the use of LKB1 as a prognostic factor ‚Ä this invention also does not utilize the methods or antibody described in this manuscript.","2013","09","Yuji Nakada","YN",10,TRUE,9,4,10,4,TRUE,TRUE,FALSE,0,NA,FALSE
